IL-36 receptor antagonist with special emphasis on IL-38.

about

Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

P2860

Q38172131-99B06124-CAFC-43A1-A27A-41BCFE98C084 Q42280842-149C36F6-D304-4A80-9730-C64A713D4644

P2860

IL-36 receptor antagonist with special emphasis on IL-38.

Item

http://www.wikidata.org/entity/Q45717455

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

IL-36 receptor antagonist with special emphasis on IL-38.

@en

IL-36 receptor antagonist with special emphasis on IL-38.

@nl

type

Item

label

IL-36 receptor antagonist with special emphasis on IL-38.

@en

IL-36 receptor antagonist with special emphasis on IL-38.

@nl

prefLabel

IL-36 receptor antagonist with special emphasis on IL-38.

@en

IL-36 receptor antagonist with special emphasis on IL-38.

@nl

P1476

IL-36 receptor antagonist with special emphasis on IL-38

@en

P2093

A Caraffa

http://www.w3.org/2001/XMLSchema#string

A Saggini

http://www.w3.org/2001/XMLSchema#string

E Cianchetti

http://www.w3.org/2001/XMLSchema#string

F Conti

http://www.w3.org/2001/XMLSchema#string

F Pandolfi

http://www.w3.org/2001/XMLSchema#string

G Murmura

http://www.w3.org/2001/XMLSchema#string

G Potalivo

http://www.w3.org/2001/XMLSchema#string

G Sabatino

http://www.w3.org/2001/XMLSchema#string

G Varvara

http://www.w3.org/2001/XMLSchema#string

M Rosati

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome

IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression

Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1

Cloning and characterization of IL-1HY2, a novel interleukin-1 family member

Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs

IL-36R ligands are potent regulators of dendritic and T cells

Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

P304

27-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/039463201302600103

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Renato Galzio

Giulio Maccauro

P Antinolfi

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23527706

http://www.w3.org/2001/XMLSchema#string

IL-36 receptor antagonist with special emphasis on IL-38.

about

P2860

P2860

IL-36 receptor antagonist with special emphasis on IL-38.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698